机译:P3.01-96 EGFR或HER2外显子20的非小细胞肺癌的临床特征
Department of Medical Oncology Kindai University Faculty of Medicine;
Department Genome Biology Kinkai University School of Medicine;
Department of Medical Oncology Kindai University Faculty of Medicine;
Department of Medical Oncology Kindai University Faculty of Medicine;
Department of Medical Oncology Kindai University Faculty of Medicine;
Department of Medical Oncology Kindai University Faculty of Medicine;
Department of Medical Oncology Kindai University Faculty of Medicine;
Department Genome Biology Kinkai University School of Medicine;
Department of Medical Oncology Kindai University Faculty of Medicine;
机译:P3.01-96 EGFR或HER2外显子20的非小细胞肺癌的临床特征
机译:Osimertinib用于高级非小细胞肺癌,涉及EGFR突变外显子20 T790M,获得第一或第二代EGFR-TKI的抗性突变
机译:P3.01-009 icotinib患者患有EGFR外显子18 E709x突变患者icotinib患者的临床疗效
机译:在非小细胞肺癌中,放射学特征可以预测EGFR突变吗?
机译:用于EGFR基因外显子18-21突变检测的LATE-PCR和开/关灯探针检测的设计,构建和验证:对非小细胞肺癌的分子诊断意义
机译:EGFR或HER2外显子20外显子突变的非小细胞肺癌的临床特征
机译:P3.01-96 EGFR或HER2外显子20的非小细胞肺癌的临床特征